AGNP Board Exam Question and Answers – Neurology Assessment

$30.00

Category: AGNP Board Exam Tag: agnp

Description

AGNP BOARD EXAM QUESTIONS Neurology Assessment (102 Questions)

  1. Which of the following medications is NOT a serotonin 5-HT1 receptor agonist?
  2.  A patient presenting with a transient ischemic attack (TIA) is taking nifedipine (Adalat CC) for hypertension. Pharmacokinetics of nifedipine may be altered in patients with:
  3. Oxcarbazepine (Trileptal) is structurally similar to:
  4. Patients who experience greater than 7 to 9 tension-type headaches per month may be considered for maintenance therapy including:
  5. Beta-blockers, used for the prophylactic treatment of migraines, would NOT be contraindicated in a patient with a history of:
  6. Patients who are taking carbidopa/levodopa (Sinemet) for Parkinson’s disease should be advised to avoid a diet high in:
  7. Which of the following statements is NOT true about antiepileptic drugs (AEDs)?
  8.  Patients who are taking divalproex sodium (Depakote) and lamotrigine (Lamictal) are at higher risk for developing:
  9. 9. Children who are receiving gabapentin (Neurontin) should be monitored for:
  10. During initiation of treatment and escalation of doses, pramipexole (Mirapex) and other dopamine agonists are known to cause:
  11. Sumatriptan (Imitrex), a serotonin (5-HT1) receptor agonist, is:
  12. Patients who require oral corticosteroids for the treatment of Bell’s Palsy should be instructed to take the medication:
  13. To be of greatest benefit, corticosteroids in the treatment of Bell’s palsy should be initiated within:
  14. Beta-blockers are contraindicated in patients with:
  15. Ropinirole (Requip), used in the treatment of restless legs syndrome (RLS), is metabolized primarily in the:
  16. Which of the following medications is an N-methyl-D-aspartate receptor antagonist for the treatment of dementia of the Alzheimer’s type?
  17. The most common short-term adverse effects of ropinirole (Requip) used in restless leg syndrome (RLS) include:
  18. Carbidopa/levodopa (Sinemet) for the treatment of Parkinson’s disease is contraindicated in patients with:
  19. Pramipexole (Mirapex), a dopamine agonist, is indicate in the treatment of:
  20. Exercise caution before initiating pregabalin (Lyrica) in combination with:
  21. The first-line treatment in acute tension-type headache is:
  22. Triptans, such as sumatriptan (Imitrex), should NOT be administer concomitantly with:
  23. The brand name of oxcarbazepine is:
  24. The first-line pharmacological option for the treatment of generalized tonic-clonic seizures is:
  25. The most common side effects relate to benztropine (Cogentin) and trihexyphenidyl, use in the treatment of parkinsonism, are:
  26. Education for patients who are taking amantadine should NOT include:
  27. The generic name for Depakote is:
  28. The primary beta-blocker indicate for the prophylactic treatment of migraine headaches is:
  29. A patient who is receive divalproex sodium (Depakote) reports acute abdominal pain accompanied by nausea and vomiting. This patient should be evaluate for:
  30. At each follow-up visit for patients who are taking carbidopa/levodopa (Sinemet), the provider should specifically inquire about:
  31. A patient who is taking beta-blockers for the prophylactic treatment of migraine headache does NOT need to be monitored for:
  32. Macrolides, such as clarithromycin (Biaxin), are NOT generally use to treat:
  33. Amantadine, an antiviral agent and an N-methyl-D-aspartate (NMDA) receptor antagonist, is indicate in the treatment of:
  34. A pediatric patient who is taking valproic acid (Depakene) may exhibit toxicity symptoms which would include:
  35. Phenobarbital, indicated for the treatment of epilepsy, is:
  36. Divalproex sodium (Depakote) for the prophylactic treatment of migraines:
  37. The brand name for levetiracetam is:
  38. Pregabalin (Lyrica) is NOT approve for the treatment of:
  39. The mechanism of action of pramipexole (Mirapex) is to:
  40. Patients receiving non-cardioselective beta blockers for migraine treatment are much more likely to experience:
  41. Levetiracetam (Keppra), indicate in the adjunctive treatment of partial seizures, is:
  42. Oral levetiracetam (Keppra) is indicate for use as:
  43. Carbidopa/levodopa (Sinemet) for the treatment of Parkinson’s disease is a(n):
  44. The most common reason patients discontinue use of pregabalin (Lyrica) is:
  45. Ergotamine alkaloids, such as dihydroergotamine (Migranal), are indicate in the treatment of:
  46. Patients taking topiramate (Topamax) are at high risk for developing:
  47. A patient was started on lamotrigine (Lamictal) 4 weeks ago, and today presents with a mild rash on the upper left thigh. The nurse practitioner should:
  48. Carbamazepine (Tegretol), used in the treatment of trigeminal neuralgia,:
  49. For treatment of Bell’s palsy, combination therapy is consider to be more beneficial and includes corticosteroids plus:
  50. The medication recommend for the rescue of refractory or cluster seizure activity is:
  51. To prevent further events, patients with transient ischemic attacks (TIAs) should be treat with:
  52. Patient who is taking valproic acid (Depakote) should have routine laboratory monitoring which includes a:
  53. Serotonin (5HT1) receptor agonists, or triptans:
  54. Primidone (Mysoline) is metabolize into two active metabolites, one of which is:
  55. The brand name for carbamazepine is:
  56. A drug interaction may occur between carbamazepine (Tegretol) and:
  57. The brand name of phenytoin sodium is:
  58. The patient who requires the LEAST cautionary measures when treated with carbidopa/levodopa (Sinemet) is:
  59. Ergotamine alkaloids for the treatment of migraines are safe to administer with:
  60. Taking a triptan (5-HT1 agonist), such as sumatriptan (Imitrex), early in the headache cycle does NOT:
  61. Carbidopa and levodopa are the active ingredients in Sinemet used to treat Parkinson’s disease. The addition of carbidopa:
  62. Which medication may be beneficial in the treatment of restless legs syndrome (RLS)?
  63. Ticlopidine (Ticlid), a platelet aggregation inhibitor,:
  64. Butalbital, one of the components of Fioricet, a medication use to abort tension-type headaches:
  65. Acetaminophen may be use to reduce fever in the presence of a febrile seizure. A severe complication of acetaminophen (Tylenol) is:
  66. Acute tension-type headaches refractory to simple analgesics may respond to a combination of analgesics and:
  67. Which medication does NOT have an indication for the treatment of Parkinson disease?
  68. The medication class that does NOT lead to postural hypotension and possible syncope is:
  69. After initiation of 300 mg serum phenytoin (Dilantin), daily levels should be checked at approximately:
  70. The generic name for Lyrica is:
  71. Non-selective beta-blockers use in migraine prophylaxis actively compete for beta receptors, inhibiting the binding of:
  72. Benztropine (Cogentin), an anticholinergic, is NOT recommend for use in patients with:
  73. A patient who is taking carbamazepine (Tegretol) for trigeminal neuralgia presents with complaints of fatigue, muscle cramps and nausea. These are symptoms of:
  74. Chronic use of phenytoin (Dilantin) has been associate with:
  75. Sumatriptan (Imitrex) is classified as a(n):
  76. Due to increase cholinergic activity in patients treated with donepezil (Aricept), patients should be monitor for:
  77. Patients who are taking rasagiline (Azilect) for the treatment of Parkinson’s disease should avoid other CYP1A2 inhibitors such as:
  78. Patients receiving oxcarbazepine (Trileptal) should be routinely monitored for:
  79. Fioricet, indicate for the abortive treatment of tension-type headache, is a combination of acetaminophen,:
  80. Which of the follow is a non-dihydropyridine calcium channel blocker?
  81. Monitor for side effects of topiramate (Topamax) includes:
  82. Patients with mild chronic obstructive pulmonary disease may receive a beta-blocker for migraine prophylaxis as long as they are not currently taking a(n): (AGNP BOARD EXAM QUESTIONS Neurology Assessment)
  83. Propranolol hydrochloride (Inderal) for the treatment of migraines:
  84. A patient receiving lamotrigine (Lamictal) for the treatment of epilepsy would NOT need routine monitoring of:
  85. In addition to the treatment of various forms of epilepsy, lamotrigine (Lamictal) is indicate in the treatment of:
  86. Syncope related to vasovagal symptoms is best treat with:
  87. Common side effects relate to pregabalin (Lyrica) include:
  88. Clopidogrel (Plavix) is consider:
  89. Clindamycin (Cleocin) is NOT indicate in the treatment of:
  90. Which medication is approve for prophylactic treatment of migraine headaches?
  91. Following an acute overdose of acetaminophen (Tylenol), patients who are at significant risk for hepatotoxicity should receive:
  92. Monitoring of patients receiving gabapentin (Neurontin) should include:
  93. Medications with significant anticholinergic properties, such as amantadine (Symmetrel) to treat Parkinson’s disease, block which neurotransmitter? (AGNP BOARD EXAM QUESTIONS Neurology Assessment)
  94. Donepezil (Aricept), a cholinesterase inhibitor, is indicate in the treatment of:
  95. The pharmacological management that provides the greatest clinical improvement of carpal tunnel syndrome is:
  96. Carbamazepine (Tegretol) is indicate in the treatment of:
  97. Divalproex sodium (Depakote) for the treatment of epilepsy can be safely administer to:
  98. A medication used in a patient with a transient ischemic attack to prevent platelet aggregation and produce an anti-inflammatory effect in vessels by inhibiting prostaglandin synthesis is:
  99. Topiramate (Topamax), an antiepileptic drug,:
  100. The LEAST important goal of pharmacologic therapy in the treatment of epilepsy is to:
  101. A common adverse reaction to clopidogrel (Plavix) is:
  102. Patients receiving levetiracetam (Keppra) are NOT likely to experience the side effect of